CRGX
Price
$4.59
Change
-$0.01 (-0.22%)
Updated
Jul 11, 03:50 PM (EDT)
Capitalization
213.98M
32 days until earnings call
RNTX
Price
$1.44
Change
-$0.05 (-3.36%)
Updated
Jul 11, 03:32 PM (EDT)
Capitalization
33.01M
Interact to see
Advertisement

CRGX vs RNTX

Header iconCRGX vs RNTX Comparison
Open Charts CRGX vs RNTXBanner chart's image
CARGO Therapeutics
Price$4.59
Change-$0.01 (-0.22%)
Volume$1.6K
Capitalization213.98M
Rein Therapeutics
Price$1.44
Change-$0.05 (-3.36%)
Volume$280
Capitalization33.01M
CRGX vs RNTX Comparison Chart in %
Loading...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRGX vs. RNTX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRGX is a StrongBuy and RNTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (CRGX: $4.60 vs. RNTX: $1.48)
Brand notoriety: CRGX and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRGX: 111% vs. RNTX: 35%
Market capitalization -- CRGX: $213.98M vs. RNTX: $33.01M
CRGX [@Biotechnology] is valued at $213.98M. RNTX’s [@Biotechnology] market capitalization is $33.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRGX’s FA Score shows that 1 FA rating(s) are green whileRNTX’s FA Score has 0 green FA rating(s).

  • CRGX’s FA Score: 1 green, 4 red.
  • RNTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRGX is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRGX’s TA Score shows that 6 TA indicator(s) are bullish while RNTX’s TA Score has 5 bullish TA indicator(s).

  • CRGX’s TA Score: 6 bullish, 4 bearish.
  • RNTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRGX is a better buy in the short-term than RNTX.

Price Growth

CRGX (@Biotechnology) experienced а +3.14% price change this week, while RNTX (@Biotechnology) price change was -1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.92%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +21.32%.

Reported Earning Dates

CRGX is expected to report earnings on Aug 12, 2025.

RNTX is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+9.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRGX($214M) has a higher market cap than RNTX($33M). RNTX YTD gains are higher at: -35.652 vs. CRGX (-68.100). RNTX has higher annual earnings (EBITDA): -26.51M vs. CRGX (-162.4M). CRGX has more cash in the bank: 319M vs. RNTX (7.43M). CRGX (0) and RNTX (0) have equivalent revenues.
CRGXRNTXCRGX / RNTX
Capitalization214M33M648%
EBITDA-162.4M-26.51M613%
Gain YTD-68.100-35.652191%
P/E RatioN/AN/A-
Revenue00-
Total Cash319M7.43M4,295%
Total Debt30.4MN/A-
FUNDAMENTALS RATINGS
RNTX: Fundamental Ratings
RNTX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRGXRNTX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQDA14.150.67
+4.97%
Liquidia Corp
PYPL75.700.87
+1.16%
PayPal Holdings
LU2.690.03
+1.13%
Lufax Holding Ltd
RADX4.200.03
+0.72%
Radiopharm Theranostics Limited
RLGT6.21-0.01
-0.16%
Radiant Logistics

CRGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRGX has been loosely correlated with IKT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CRGX jumps, then IKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRGX
1D Price
Change %
CRGX100%
N/A
IKT - CRGX
44%
Loosely correlated
-0.99%
ALLO - CRGX
41%
Loosely correlated
+4.13%
CRNX - CRGX
39%
Loosely correlated
-1.05%
PRME - CRGX
38%
Loosely correlated
+3.30%
CELC - CRGX
37%
Loosely correlated
+0.81%
More

RNTX and

Correlation & Price change

A.I.dvisor tells us that RNTX and ATOS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNTX and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-0.67%
ATOS - RNTX
30%
Poorly correlated
-1.34%
ERNA - RNTX
26%
Poorly correlated
+1.54%
IKT - RNTX
26%
Poorly correlated
-0.99%
CRGX - RNTX
25%
Poorly correlated
N/A
SYBX - RNTX
23%
Poorly correlated
N/A
More